Loge C - Search Results

1

Three-dimensional model of cytochrome P450 human aromatase.

Loge C, Le Borgne M, Marchand P, Robert JM, Le Baut G, Palzer M, Hartmann RW. Loge C, et al. J Enzyme Inhib Med Chem. 2005 Dec;20(6):581-5. doi: 10.1080/14756360500220574. J Enzyme Inhib Med Chem. 2005. PMID: 16408794 Free article.

2

Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885.

Logé C, Wallez V, Scalbert E, Cario-Tourmaniantz C, Loirand G, Pacaud P, Lesieur D. Logé C, et al. J Enzyme Inhib Med Chem. 2002 Dec;17(6):381-90. doi: 10.1080/1475636021000005659. J Enzyme Inhib Med Chem. 2002. PMID: 12683673 Free article.

3

Synthesis and pharmacological study of Rho-kinase inhibitors: pharmacomodulations on the lead compound Fasudil.

Logé C, Siomboing X, Wallez V, Scalbert E, Bennejean C, Cario-Tourmaniantz C, Loirand G, Gressier B, Pacaud P, Luyckx M. Logé C, et al. J Enzyme Inhib Med Chem. 2003 Apr;18(2):127-38. doi: 10.1080/1475636031000093561. J Enzyme Inhib Med Chem. 2003. PMID: 12943196 Free article.

4

Docking study of ligands into the colchicine binding site of tubulin.

Farce A, Loge C, Gallet S, Lebegue N, Carato P, Chavatte P, Berthelot P, Lesieur D. Farce A, et al. Among authors: loge c. J Enzyme Inhib Med Chem. 2004 Dec;19(6):541-7. doi: 10.1080/14756360412331280545. J Enzyme Inhib Med Chem. 2004. PMID: 15662957 Free article.

5

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.

Testard A, Logé C, Léger B, Robert JM, Lozach O, Blairvacq M, Meijer L, Thiéry V, Besson T. Testard A, et al. Among authors: loge c. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3419-23. doi: 10.1016/j.bmcl.2006.04.006. Epub 2006 Apr 27. Bioorg Med Chem Lett. 2006. PMID: 16644220

6

A 3D-QSAR CoMSIA study on 3-azolylmethylindoles as anti-leishmanial agents.

Giraud F, Loge C, Le Borgne M, Pagniez F, Na YM, Le Pape P. Giraud F, et al. Among authors: loge c. SAR QSAR Environ Res. 2006 Jun;17(3):299-309. doi: 10.1080/10659360600787494. SAR QSAR Environ Res. 2006. PMID: 16815769

7

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies.

Logé C, Testard A, Thiéry V, Lozach O, Blairvacq M, Robert JM, Meijer L, Besson T. Logé C, et al. Eur J Med Chem. 2008 Jul;43(7):1469-77. doi: 10.1016/j.ejmech.2007.09.020. Epub 2007 Sep 29. Eur J Med Chem. 2008. PMID: 17981370

8

Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Giraud F, Logé C, Pagniez F, Crepin D, Le Pape P, Le Borgne M. Giraud F, et al. Among authors: loge c. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1820-4. doi: 10.1016/j.bmcl.2008.02.027. Epub 2008 Feb 14. Bioorg Med Chem Lett. 2008. PMID: 18313295

9

Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.

Jacquemard U, Dias N, Lansiaux A, Bailly C, Logé C, Robert JM, Lozach O, Meijer L, Mérour JY, Routier S. Jacquemard U, et al. Among authors: loge c. Bioorg Med Chem. 2008 May 1;16(9):4932-53. doi: 10.1016/j.bmc.2008.03.034. Epub 2008 Mar 17. Bioorg Med Chem. 2008. PMID: 18439832

10

Design, synthesis and evaluation of new 6-substituted-5-benzyloxy-4-oxo-4H-pyran-2-carboxamides as potential Src inhibitors.

Farard J, Lanceart G, Logé C, Nourrisson MR, Cruzalegui F, Pfeiffer B, Duflos M. Farard J, et al. Among authors: loge c. J Enzyme Inhib Med Chem. 2008 Oct;23(5):629-40. doi: 10.1080/14756360802205299. J Enzyme Inhib Med Chem. 2008. PMID: 18686137 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters